Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scalable differentiation of human cardiac organoids from iPSCs generates cardiac tissues for cardiac cell therapy.

Theranostics·2026
Same author

Comparison Between Titanium and Polyether Ether Ketone Cranioplasty Based on Preoperative Imaging Indicators and Analysis of Risk Factors for Postoperative Adverse Events.

World neurosurgery·2026
Same author

Systematic analyses to explore kinase gene set-based signature in glioma, in which WEE1 contributes to tumor progression.

Discover oncology·2026
Same author

Sequential manifestation of Kaposi's sarcoma and diffuse large B-cell lymphoma in the context of HIV infection: Case report of a rare presentation.

Medicine·2026
Same author

Focal Adhesion Related Gene Signature for Glioma: The Pivotal Role of RAP1B in Disease Progression.

Current medicinal chemistry·2026
Same author

High-power dual-channel chamber for high-frequency magnetic neuromodulation.

Journal of neural engineering·2026

Related Experiment Video

Updated: Sep 18, 2025

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.2K

Cell-Based Therapies: Ferromagnetic Versus Superparamagnetic Cell Targeting.

Tasneem Halhouli1,2, Lisa Münchhalfen1,2, Sarkawt Hamad1,2,3

  • 1Center for Physiology and Pathophysiology, Institute for Neurophysiology, University of Cologne, Medical Faculty and University Hospital of Cologne, 50931 Cologne, Germany.

Bioengineering (Basel, Switzerland)
|June 26, 2025
PubMed
Summary

Magnetic cell targeting using superparamagnetic iron oxide nanoparticles (SPIONs) enhances stem cell therapy. SPIONs improve mesenchymal stem cell (MSC) adhesion and clustering, increasing therapeutic efficiency in injured tissues.

Keywords:
ferromagnetic particlesmurine MSCssuperparamagnetic iron oxide nanoparticles (SPIONs)

More Related Videos

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
10:23

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells

Published on: December 13, 2016

10.1K
Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
11:37

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

6.7K

Related Experiment Videos

Last Updated: Sep 18, 2025

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles
08:26

Cell Labeling and Targeting with Superparamagnetic Iron Oxide Nanoparticles

Published on: October 19, 2015

12.2K
Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
10:23

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells

Published on: December 13, 2016

10.1K
Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
11:37

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

6.7K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Nanotechnology

Background:

  • Stem-cell-based therapies offer potential for tissue repair but often face challenges with low cell engraftment efficiency.
  • Magnetic cell targeting presents a promising strategy to improve the retention and delivery of transplanted cells to injured sites.

Purpose of the Study:

  • To investigate the efficacy of superparamagnetic iron oxide nanoparticles (SPIONs) for magnetic labeling and targeting of mesenchymal stem cells (MSCs).
  • To evaluate the impact of magnetic targeting on MSC adhesion kinetics and cell clustering for enhanced engraftment in regenerative medicine.

Main Methods:

  • Intracellular magnetic loading of MSCs with SPIONs and ferromagnetic particles.
  • Adhesion assays to quantify spheroid adhesion under magnetic field application.
  • Cell clustering assays to assess cell aggregation in the presence of a magnetic field.

Main Results:

  • SPIONs-loaded MSC spheroids exhibited significantly faster adhesion kinetics (>50% adhesion in 30 min) when a magnetic field was applied.
  • Magnetic fields induced rapid cell clustering (>80% aggregation in 10 min), with SPIONs-loaded and ferromagnetic-particle-loaded cells performing comparably.
  • Cellular clustering was identified as a key mechanism for magnetic cell retention, explaining maximal targeting efficiency within 10 minutes.

Conclusions:

  • Magnetic targeting using SPIONs effectively enhances MSC adhesion and clustering, improving cell retention in target tissues.
  • The rapid cellular aggregation observed suggests a 10-minute magnetic field application is sufficient for maximal in vivo targeting efficiency.
  • This approach holds significant promise for advancing magnetic-targeting-assisted stem cell therapies and cell replacement strategies.